Skip to content
healthcare.dev

Methotrexate

NDC 63323-122, METHOTREXATE SODIUM, injection, powder, lyophilized, for solution, from Fresenius Kabi USA, LLC.

Product NDC
63323-122
Status
Listed
Labeler
Fresenius Kabi USA, LLC
Dosage form
INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Route
INTRA-ARTERIAL, INTRAMUSCULAR, INTRATHECAL, INTRAVENOUS
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA040266
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/63323-122 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • METHOTREXATE SODIUM1 g/1

Pharmacologic classes

Folate Analog Metabolic Inhibitor [EPC]; Folic Acid Metabolism Inhibitors [MoA]

Package NDCNDC-11Package
63323-122-50633230122501 VIAL in 1 CARTON (63323-122-50) / 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/ec476b11-0b3c-4139-b1eb-a3daa76bc271
  • Medicare Part B payment limits (ASP)

    GET /v1/drugs/asp?ndc=63323-122

Use it

Look up 63323-122 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/63323-122 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 63323-122. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.